Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Year of publication
- 2020 (10) (remove)
Document Type
- Journal article (10) (remove)
Language
- English (10)
Keywords
- identification (2)
- 3D tissue models (1)
- 6-benzylaminopurine (1)
- Axl tyrosine kinase (1)
- BRAF mutation (1)
- CLV3p (1)
- Chagas diagnosis (1)
- Chagas disease (1)
- Chagas monitoring (1)
- Chagas real time PCR (1)
- Gene expression vectors (1)
- ICP27 (1)
- Polymerase chain reaction (1)
- Sanger sequencing (1)
- Shotgun method (1)
- Staphylococcus aureus (1)
- Synthetic biology (1)
- Trypanosoma cruzi (1)
- Virtual sequencing (1)
- annotation (1)
- anti-cancer drug-like molecules (1)
- binding protein (1)
- calcium signaling pathway (1)
- cascade (1)
- cell death (1)
- colorectal cancer (1)
- cycle (1)
- cytokinins (1)
- database (1)
- defense signaling (1)
- domain (1)
- drosophila (1)
- evolutionary (1)
- expression (1)
- facultatively intracellular pathogens (1)
- human (1)
- in silico simulation (1)
- infected-cell protein (1)
- interaction map (1)
- interactome (1)
- interspecies comparison (1)
- messenger RNA (1)
- meta-transcriptome (1)
- molecular docking (1)
- molecular dynamics (1)
- mouse (1)
- network (1)
- platelet (1)
- proteome (1)
- rational drug design (1)
- reliability (1)
- sequence (1)
- shoot apical meristem (1)
- signaling (1)
- stem-cell-triggered immunity (1)
- stratification (1)
- system inference (1)
- target (1)
- targeted therapy (1)
- transcriptome (1)
- translation (1)
- type 1 (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (10) (remove)
EU-Project number / Contract (GA) number
Background: Chagas disease (CD) is a major burden in Latin America, expanding also to non-endemic countries. A gold standard to detect the CD causing pathogen Trypanosoma cruzi is currently not available. Existing real time polymerase chain reactions (RT-PCRs) lack sensitivity and/or specificity. We present a new, highly specific RT-PCR for the diagnosis and monitoring of CD. Material and Methods: We analyzed 352 serum samples from Indigenous people living in high endemic CD areas of Colombia using three leading RT-PCRs (k-DNA-, TCZ-, 18S rRNA-PCR), the newly developed one (NDO-PCR), a Rapid Test/enzyme-linked immuno sorbent assay (ELISA), and immunofluorescence. Eighty-seven PCR-products were verified by sequence analysis after plasmid vector preparation. Results: The NDO-PCR showed the highest sensitivity (92.3%), specificity (100%), and accuracy (94.3%) for T. cruzi detection in the 87 sequenced samples. Sensitivities and specificities of the kDNA-PCR were 89.2%/22.7%, 20.5%/100% for TCZ-PCR, and 1.5%/100% for the 18S rRNA-PCR. The kDNA-PCR revealed a 77.3% false positive rate, mostly due to cross-reactions with T. rangeli (NDO-PCR 0%). TCZ- and 18S rRNA-PCR showed a false negative rate of 79.5% and 98.5% (NDO-PCR 7.7%), respectively. Conclusions: The NDO-PCR demonstrated the highest specificity, sensitivity, and accuracy compared to leading PCRs. Together with serologic tests, it can be considered as a reliable tool for CD detection and can improve CD management significantly.